Onkološki inštitut Ljubljana (OILJ)
  • High proportion of complete radiologic and metabolic response and prolonged progression-free survival after intercalated chemotherapy and erlotinib for advanced NSCLC with activating EGFR mutations
    Zwitter, Matjaž ...
    Vir: Journal of thoracic oncology. - ISSN 1556-0864 (Vol. 9, suppl. 1, 2014, Str. [1])
    Vrsta gradiva - prispevek na konferenci
    Leto - 2014
    Jezik - angleški
    COBISS.SI-ID - 1744507

vir: Journal of thoracic oncology. - ISSN 1556-0864 (Vol. 9, suppl. 1, 2014, Str. [1])

loading ...
loading ...
loading ...